Research suggests that BPC-157 can protect and repair the gastrointestinal mucosa, the lining of the digestive tract, by reducing inflammation and enhancing tissue integrity
This unique mechanism enables BPC-157 to promote healing throughout the entire wound repair process from initial inflammation through final tissue remodeling phases
Preclinical toxicology studies in animals showed no concerning findings with chronic administration, but human long-term data would strengthen confidence in extended protocols
For a general deficiency, many protocols start with 100 mcg injections daily or every other day for the first week
Researchers study it for tissue repair, angiogenesis, tendon-to-bone healing, and gastrointestinal mucosal protection
However, the research is in very early stages, and no definitive conclusions about cancer protection or risk can be drawn from current data